�ٺ���Ƶ

News from �ٺ���Ƶ Health

11 Health Systems Leading In AI. (Becker's Hospital Review)

(9/5) �ٺ���Ƶ Health has been recognized as a leader in AI by Becker’s Healthcare, in partnership with the Joan and Irwin Jacobs Center for Health Innovation at UC San Diego, for its significant advancements in digital health innovation, particularly through the efforts of the Center for Healthcare Innovation and Delivery Science and the Predictive Analytics Unit in the MCIT Department of Health Informatics, which utilizes data and modeling to predict health outcomes. Nader Mherabi, executive vice president, vice dean, and chief digital and information officer, stated, “We are committed to enhancing workflows, revolutionizing the digital patient experience, and leveraging big data to improve care and efficiency,” and Yindalon Aphinyanaphongs, MD, PhD, assistant professor, Departments of Population Health, and Medicine, Division of Hospital Medicine, leads a team focused on transforming healthcare through AI.

World Trade Center Exposure Linked To Increased DNA Methylation. (HealthDay)

(9/5) A study published in Environmental Epidemiology associates World Trade Center exposure with increased DNA methylation, which may contribute to breast cancer, led by senior author Alan A. Arslan, associate professor, Departments of Obstetrics and Gynecology, and Population Health, examined DNA methylation profiles of WTC-exposed community members, comparing 64 women (32 cancer-free, 32 with breast cancer) to 32 unexposed women from the NYU Women’s Health Study (16 cancer-free, 16 with prediagnostic breast cancer).

Daily Vs Weekly Step Goal: Which Is More Effective? (TODAY)

(9/5) Natasha N. Desai, MD, clinical assistant professor, Department of Orthopedic Surgery, Division of Sports Medicine, Women’s Sports Medicine Center, discusses the benefits of walking, describing it as a free, accessible, low-impact activity that can be self-paced, which makes it suitable for rehabilitation, general health, or weight loss goals, and suggests that individuals should determine their goals and the best way to measure them, whether by daily steps or weekly totals.

What 5 Doctors Are Excited About In Kidney Cancer Research. (TIME)

(9/5) “‘Most kidney cancers are found by accident quite early, because people get scans for unrelated reasons,’ says William C. Huang, MD, vice chair for clinical affairs, professor, Department of Urology, and professor, Department of Radiology, Perlmutter Cancer Center.”

How NFL’s ‘Hip-Drop’ Tackle Ban Protects Players. (New York Post)

The (9/5) “Guillem Gonzalez-Lomas, MD, assistant professor, Department of Orthopedic Surgery joins New York Post Sports anchor Brandon London for the weekly ‘Injury Report’ segment to explain how the NFL’s institution of a ‘hip-drop’ tackle ban can protect players from sustaining lower body injuries.”

Regular Cell Phone Use Linked To Higher Heart Disease Risk. (Medscape)

Paywalled* (9/6)* A UK Biobank analysis links using a cell phone for at least one call per week to a higher risk for cardiovascular disease, particularly among smokers and diabetes patients; Nieca Goldberg, MD, clinical associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, suggested patients be mindful of phone use’s impact on physical activity, sleep, and stress, adding, “It would be important for future studies to look at time spent on the phone and the type of activities patients are doing on their phones, such as social media, calls, texts, movies, or streaming TV shows.”

Dr Stacy Loeb On Obtaining Board Certification In Lifestyle Medicine. (Urology Times)

The (9/5) “Thriving in Urology,” a new video series hosted by Dr. Amy M. Pearlman of the Prime Institute in Coral Gables, Florida, features Stacy Loeb, MD, professor, Departments of Urology and Population Health, Perlmutter Cancer Center, discussing sources of burnout and how she finds fulfillment in her career.

Chemo Option Cuts Side Effects For GI Cancers. (Mirage News (AUS))

(9/5) New research published by JNCCN-Journal of the National Comprehensive Cancer Network finds that for many treatment regimens targeting metastatic gastrointestinal cancers, such as FOLFOX, FOLFIRI, or FOLFIRINOX, administering 5-FU solely through continuous infusion without the bolus component does not negatively affect patient outcomes; Shun Yu, MD, clinical assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, said, “The most significant benefit of this adjustment is that it makes the treatment more tolerable, potentially easing the chemotherapy experience for patients.”

Explore Meaning And Values To Provide Direction In Uncertainty. (Psychology Today)

(9/5) Robert M. Gordon, PsyD, clinical associate professor, Department of Rehabilitation Medicine, Elizabeth L. Malkin, PsyD, MSCP, and Elizabeth Choi, Ph.D., explore how individuals can navigate feelings of vulnerability and existential distress caused by global stressors and personal adversities by focusing on meaning in life and core values, referencing psychotherapeutic approaches such as Meaning-Centered Psychotherapy (MCP) and Acceptance and Commitment Therapy (ACT), which help align actions with values and foster psychological resilience.

Business Openings: Care On Demand, Morelia, Club Pilates, Casasalvo. (East Side Feed)

(9/5) �ٺ���Ƶ Health has launched �ٺ���Ƶ Care on Demand at 1465 Third Avenue at 83rd Street and in the West Village, providing an appointment-free method for New Yorkers to access primary care, with clinicians treating common health issues.

The Best Squatty Potty And Other Toilet Stools Worth The Floor Space. (New York Times)

The (9/5) Sophie M. Balzora, MD, clinical professor, Department of Medicine, Division of Gastroenterology and Inflammatory Bowel Disease, explained that toilet stools can enhance the bowel movement experience by simulating a squatting position, which aligns the anus and rectum more effectively, thereby straightening the colon and facilitating a smoother exit for stool.

Breast Cancer Drug Could Help Prolong Survival For Children With Brain Tumors, Study Finds. (Fox News)

(9/5) A new study suggests that ribociclib, a drug used to treat breast cancer, could slow the progression of certain pediatric high-grade gliomas, an aggressive type of childhood brain cancer; Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, remarked on the drug’s potential, stating, “This is a targeted therapy that has been used in breast cancer to attack growth factors on the surface of the cancer.”